PLoS ONE · 2014 · 30 citations · 26 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationInnate ImmunityAnti-inflammatory PharmacologyCytokine BiologyInflammatory SignalingMicroglia BiologyNeuroinflammationNeuroprotectionAnti-inflammatory Drug DiscoveryAnti-inflammatory MechanismsAnti-inflammatory TherapeuticsMap KinasesMicroglia ActivationMicroglia ModulationMicroglial Activation Gene ExpressionNeuroinflammation Modulation
Microglial activation plays a pivotal role in the development and progression of neurodegenerative diseases. Thus, anti-inflammatory agents that control microglial activation can serve as potential therapeutic agents for neurodegenerative diseases. Here, we designed and synthesized α-galactosylceramide (α-GalCer) analogs to exert anti-inflammatory effects in activated microglia. We performed biological evaluations of 25 α-GalCer analogs and observed an interesting preliminary structure-activity relationship in their inhibitory influence on NO release and TNF-α production in LPS-stimulated BV2 microglial cells. After identification of 4d and 4e as hit compounds, we further investigated the underlying mechanism of their anti-inflammatory effects using RT-PCR analysis. We confirmed that 4d and 4e regulate the expression of iNOS, COX-2, IL-1β, and IL-6 at the mRNA level and the expression of TNF-α at the post-transcriptional level. In addition, both 4d and 4e inhibited LPS-induced DNA binding activities of NF-κB and AP-1 and phosphorylation of p38 MAPK without affecting other MAP kinases. When we examined the anti-inflammatory effect of a p38 MAPK-specific inhibitor, SB203580, on microglial activation, we observed an identical inhibitory pattern as that of 4d and 4e, not only on NO and TNF-α production but also on the DNA binding activities of NF-κB and AP-1. Taken together, these results suggest that p38 MAPK plays an important role in the anti-inflammatory effects of 4d and 4e via the modulation of NF-κB and AP-1 activities.
26
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Lena Alexopoulou, Agnieszka Czopik Holt, Ruslan Medzhitov et al. · Nature · 2001 · 6.1K citations
CD1d-Restricted and TCR-Mediated Activation of V <sub>α</sub> 14 NKT Cells by Glycosylceramides
Tetsu Kawano, Junqing Cui, Yasuhiko Koezuka et al. · Science · 1997 · 2.4K citations
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull, Michelle L. Block · Neurotherapeutics · 2010 · 1K citations · Full text
Hidemitsu Kitamura, Kenji Iwakabe, Takashi Yahata et al. · The Journal of Experimental Medicine · 1999 · 620 citations · Full text